Virtual Reality During the Removal of Chest Drains in Critically-ill Patients

Sponsor
Gemma Via Clavero (Other)
Overall Status
Recruiting
CT.gov ID
NCT05332119
Collaborator
(none)
78
1
2
26.9
2.9

Study Details

Study Description

Brief Summary

Appropriate pain and anxiety management of critically-ill patients during bedside procedures remains a big challenge. Clinical Practice Guidelines recommend preemptive analgesia or non-pharmacological interventions, such as relaxation techniques or distraction, to prevent and treat pain during nursing procedures. One of the most painful procedures in the Intensive Care Unit (ICU) is the removal of chest drains in post-cardiac surgical patients.

Virtual reality (VR) is a computer-generated simulation of a 360º immersive world in which the patient can receive visual and auditory stimuli that distract them from the real environment. Current research has demonstrated that VR reduced pain and anxiety in intravenous catheter insertions or wound care.

The primary objective of the study is to evaluate the effectiveness of VR on pain and anxiety during the removal of chest drains, in post-cardiac surgical patients. The hypothesis is that VR reduces both pain and anxiety, in critically-ill patients, during the removal of chest drains in post-cardiac surgical patients.

Condition or Disease Intervention/Treatment Phase
  • Device: VR glasses
  • Other: Control group
N/A

Detailed Description

This is a prospective, randomized, open-label, prospective study of two parallel groups of patients during the removal of chest drains:

Group 1: removal of chest drains according to the usual management protocol.

Group 2: removal of chest drains according to the usual management protocol supplemented by the use of virtual reality glasses (VR glasses)

Study Design

Study Type:
Interventional
Anticipated Enrollment :
78 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Each patient will be randomized in a 1:1 ratio between the two arms of the studyEach patient will be randomized in a 1:1 ratio between the two arms of the study
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Effectiveness of Virtual Reality on Pain and Anxiety During the Removal of Chest Drains in Critically-ill Patients
Actual Study Start Date :
Apr 1, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Virtual reality

The intervention will consist of the use of VR glasses during the removal of chest drains. The VR content has been developed by VR Pharma Immersive Technologies (LtD). Its main objective is to improve patient experience and have better management of pain and anxiety. Chest drains are removed following the usual protocol.

Device: VR glasses
Patients will watch a virtual world in VR glasses during the painful procedure. They will be able to choose between 3 VR content based on their preferences.

Sham Comparator: Control group

Patients in the control group will be cared for with the usual care protocol.

Other: Control group
Patients will not receive distraction during chest drain removal

Outcome Measures

Primary Outcome Measures

  1. Procedural pain score [Baseline]

    Numerical rating scale (NRS). The pain can be scored from 0 to 10 (0=no pain, 10= worst possible pain)

  2. Procedural pain score [1 minute after the removal of chest drains]

    Numerical rating scale (NRS). The pain can be scored from 0 to 10 (0=no pain, 10= worst possible pain)

  3. Procedural pain score [30 minutes after the removal of chest drains]

    Numerical rating scale (NRS). The pain can be scored from 0 to 10 (0=no pain, 10= worst possible pain)

  4. Procedural anxiety score [Baseline]

    State-Trait Anxiety Inventory (STAI scale)- trait state. The anxiety can be scored from 0 to 60 (0=no anxiety, 60=worst possible anxiety)

  5. Procedural anxiety score [1 minute after the removal of chest drains]

    State-Trait Anxiety Inventory (STAI scale)- trait state. The anxisety can be scored from 0 to 60 (0=no anxiety, 60=worst possible anxiety)

  6. Procedural anxiety score [30 minutes after the removal of chest drains]

    State-Trait Anxiety Inventory (STAI scale)- trait state. The anxisety can be scored from 0 to 60 (0=no anxiety, 60=worst possible anxiety)

Secondary Outcome Measures

  1. Sociodemographic and clinical factors [Baseline]

    Age, gender, past medical history

  2. Blood pressure [Baseline]

    Systolic, Diastolic and mean blood pressure measure in mmHg

  3. Blood pressure [1 minute after the removal of chest drains]

    Systolic, Diastolic and mean blood pressure measure in mmHg

  4. Blood pressure [30 minutes after the removal of chest drains]

    Number of systolic, diastolic and mean blood pressure measure in mmHg

  5. Heart rate [Baseline]

    Number in beats per minute

  6. Heart rate [1minute after the removal of chest drains]

    Number in beats per minute

  7. Heart rate [30 minutes after the removal of chest drains]

    Number in beats per minute

  8. Respiratory rate [Baseline]

    Number in breaths per minute

  9. Respiratory rate [1 minute after the removal of chest drains]

    Number in breaths per minute

  10. Respiratory rate [30 minutes after the removal of chest drains]

    Number in breaths per minute

  11. Type of cardiac surgery [Baseline]

    Type

  12. Type of chest drains [At baseline]

    Mediastinal or pleural drains

  13. Number of chest drains [At baseline]

    Number

  14. Dose of analgesic drugs [1 hour before the procedure]

    Cumulated dose of analgesia drugs

  15. Patient satisfaction [30 minutes]

    Numerical Rating Scale (NRS). Patient's satisfaction will be scored from 0 to 4 (0= unsatisfied, 4=very satisfied).

  16. Adverse events [30 minutes]

    Type of adverse events experienced by patients

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients ≥ 18 years old

  • Patients with Richmond Agitation-Sedation Scale (RASS) between -1 to RASS +1

  • Patients undergoing cardiac surgery

  • Patients with chest drains

  • Patients who voluntarily agree to participate (informed consent form)

Exclusion Criteria:
  • Patients with a language barrier

  • Patients with cognitive impairments

  • Patients with neuromuscular blockers

  • Patients with a previous history of documented anxiety

  • Patients with epilepsy

  • Hemodynamically unstable patients

  • Face or ocular infections, with could contaminate VR glasses

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Universitari de Bellvitge L'Hospitalet De Llobregat Barcelona Spain 08907

Sponsors and Collaborators

  • Gemma Via Clavero

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Gemma Via Clavero, PhD. Advanced Practice Critical Care Nurse, Hospital Universitari de Bellvitge
ClinicalTrials.gov Identifier:
NCT05332119
Other Study ID Numbers:
  • ICPS001/22
First Posted:
Apr 18, 2022
Last Update Posted:
Apr 18, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Gemma Via Clavero, PhD. Advanced Practice Critical Care Nurse, Hospital Universitari de Bellvitge
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 18, 2022